Intermittent chloroquine treatment extended lifespan in female rats while preventing mammary hyperplasia and reducing circulating LDL and IGFBP3—markers associated with metabolic dysfunction and tissue overgrowth. This intervention operates through cellular clearance mechanisms, suggesting a pathway distinct from standard pharmaceutical approaches to longevity.
Key Points
- Intermittent chloroquine dosing extended lifespan in female rats
- Prevented mammary hyperplasia while lowering LDL and IGFBP3
- Mechanism involves enhanced cellular autophagy and metabolic signaling
Longevity Analysis
The capacity to clear cellular debris and regulate growth factor signaling represents a fundamental constraint on aging. This work demonstrates that targeted intermittent pharmacological intervention can improve multiple protective mechanisms simultaneously—reducing circulating markers of metabolic stress, preventing tissue overgrowth, and extending survival. The female-specific findings warrant attention given sex differences in metabolic rate, hormone sensitivity, and tissue remodeling, which may influence both the efficacy and the applicability of such approaches across populations.
Original published by Nature - npj Aging, by Marius Viorel Ionica.